Clinical Trial Update: Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure

View source ↗

Summary

This completed clinical trial evaluates a predictive model for 3-month mortality risk in patients with acute-on-chronic liver failure related to hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• On Chronic Liver Failure

Snippet

Sponsor: Wenzhou Medical University | Conditions: Acute-on-chronic Hepatitis B Liver Failure | Status: COMPLETED